Saturday, 24 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDeals

BRIM Biotechnology Raises $45.8 Million in Premium Share Issue for Pipeline Expansion

November 20, 2024
CompanyDeals

Suzhou Acumen Biomedical Secures $13.8 Million in Series A+ Funding Round

November 20, 2024
CompanyMedical Device

MicroPort MedBot’s SkyWalker Robot Approved for Orthopedic Surgery by NMPA

November 20, 2024
CompanyDrug

Zhejiang Medicine Gets NMPA Approval for NCB003 Clinical Study for Advanced Solid Tumors

November 20, 2024
CompanyDrug

Zelgen Biopharmaceuticals’ rhTSH Achieves Primary Endpoint in Phase III Study

November 20, 2024
Policy / Regulatory

China’s CDE Proposes Removal of Ambroxol Inhalation Solution and Four Other Drugs

November 20, 2024
CompanyDrug

CSBIO’s Albenatide Shows Positive Results in Two Phase III Diabetes Trials

November 20, 2024
CompanyDrug

Sandoz Receives Positive CHMP Review for Trastuzumab Biosimilar in HER2-Positive Cancers

November 20, 2024
Policy / Regulatory

NMPA Drafts Quality Management Norms for Online Medical Device Sales

November 20, 2024
Policy / Regulatory

NMPA Seeks Comments on Medical Device Classification Draft Proposal

November 20, 2024
CompanyDrug

Gilead’s Kite CAR-T Therapy Yescarta Achieves 71% CMR in Phase II Trial for R/R LBCL Patients

November 20, 2024
CompanyDeals

Pharmanovia Bolsters Neurology Portfolio with Acquisition of Sanofi’s CNS Products

November 20, 2024
1 2 … 8 9 10 11 12 … 24 25
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up